GW&K Investment Management, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$3,000
-100.0%
340
-99.8%
0.00%
-100.0%
Q3 2021$6,599,000
-9.0%
194,188
-2.0%
0.06%
-6.3%
Q2 2021$7,251,000
-20.0%
198,068
-2.0%
0.06%
-24.1%
Q1 2021$9,061,000202,0780.08%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders